SCHEMBL25462078

SCHEMBL25462078

c1ccc2c(-c3cccc4sc5cccnc5c34)ncnc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.42
LIMK1 P53667 3/20 0.38
CLK1 P49759 1/20 0.37
PDE10A Q9Y233 2/20 0.34
PI4KA P42356 1/20 0.34
PI4K2B Q8TCG2 1/20 0.34
PI4K2A Q9BTU6 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 2/20 0.33
GRM4 Q14833 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29381921 0.77 LMNA (0.49) ADORA2APDE10API4KAPI4K2BPI4K2A
SCHEMBL25461671 0.77 ADORA2A (0.43) ADORA2ALIMK1PI4KAPI4K2BPI4K2A
SCHEMBL25462074 0.75 KDM4E (0.39) LIMK1CLK1PDE10ASMN1; SMN2KDM4E
SCHEMBL25462079 0.73 LIMK1 (0.35) LIMK1CLK1PDE10ASMN1; SMN2KDM4E
SCHEMBL24596451 0.73 ADORA2A (0.47) ADORA2ALIMK1PI4KAPI4K2BPI4K2A
SCHEMBL25462758 0.72 LIMK1 (0.38) LIMK1CA12CA1CA2CA9
SCHEMBL25462044 0.72 ADORA2A (0.46) ADORA2ALIMK1PI4KAPI4K2BPI4K2A
SCHEMBL25462064 0.71 CYP1A2 (0.46) LIMK1CLK1PDE10ASMN1; SMN2KDM4E
SCHEMBL25462071 0.70 KDM4E (0.38) LIMK1PDE10ASMN1; SMN2KDM4EALDH1A1
SCHEMBL26266958 0.70 ADORA2A (0.50) ADORA2ALIMK1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 ADORA2A 3563/4885LIMK1 351/4885CLK1 3888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.